share_log

Revance Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Beryl Capital Management LLC(1.6%),Beryl Capital Management LP(1.6%), etc.

SEC ·  Sep 17 05:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more